The Retrospective Evaluation of Efficacy and Safety Data after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10) in Patients Diagnosed with Systemic Lupus Erythematosus: A Single-Center Experience


EKİN A., MISIRCI S., COŞKUN B. N., YAĞIZ B., DALKILIÇ H. E., PEHLİVAN Y.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.28, sa.10, ss.3513-3522, 2024 (SCI-Expanded) identifier identifier